• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对患有中重度肺部疾病的囊性纤维化患者气道微生物群进行非靶向宏基因组学研究。

Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease.

作者信息

Bacci Giovanni, Taccetti Giovanni, Dolce Daniela, Armanini Federica, Segata Nicola, Di Cesare Francesca, Lucidi Vincenzina, Fiscarelli Ersilia, Morelli Patrizia, Casciaro Rosaria, Negroni Anna, Mengoni Alessio, Bevivino Annamaria

机构信息

Department of Biology, University of Florence, Sesto Fiorentino, 50019 Florence, Italy.

Cystic Fibrosis Center, Anna Meyer Children's University Hospital, Department of Pediatrics Medicine, 50139 Florence, Italy.

出版信息

Microorganisms. 2020 Jul 4;8(7):1003. doi: 10.3390/microorganisms8071003.

DOI:10.3390/microorganisms8071003
PMID:32635564
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7409339/
Abstract

Although the cystic fibrosis (CF) lung microbiota has been characterized in several studies, little is still known about the temporal changes occurring at the whole microbiome level using untargeted metagenomic analysis. The aim of this study was to investigate the taxonomic and functional temporal dynamics of the lower airway microbiome in a cohort of CF patients. Multiple sputum samples were collected over 15 months from 22 patients with advanced lung disease regularly attending three Italian CF Centers, given a total of 79 samples. DNA extracted from samples was subjected to shotgun metagenomic sequencing allowing both strain-level taxonomic profiling and assessment of the functional metagenomic repertoire. High inter-patient taxonomic heterogeneity was found with short-term compositional changes across clinical status. Each patient exhibited distinct sputum microbial communities at the taxonomic level, and strain-specific colonization of both traditional and atypical CF pathogens. A large core set of genes, including antibiotic resistance genes, were shared across patients despite observed differences in clinical status, and consistently detected in the lung microbiome of all subjects independently from known antibiotic exposure. In conclusion, an overall stability in the microbiome-associated genes was found despite taxonomic fluctuations of the communities.

摘要

尽管在多项研究中已对囊性纤维化(CF)肺部微生物群进行了特征描述,但使用非靶向宏基因组分析对整个微生物组水平上发生的时间变化仍知之甚少。本研究的目的是调查一组CF患者下呼吸道微生物组的分类学和功能时间动态。在15个月内,从定期就诊于三个意大利CF中心的22例晚期肺病患者中采集了多个痰液样本,共获得79个样本。从样本中提取的DNA进行鸟枪法宏基因组测序,从而实现菌株水平的分类学分析和功能宏基因组库评估。研究发现患者间分类学异质性较高,且临床状态存在短期组成变化。每位患者在分类学水平上均表现出独特的痰液微生物群落,以及传统和非典型CF病原体的菌株特异性定植。尽管观察到临床状态存在差异,但包括抗生素抗性基因在内的大量核心基因集在患者之间是共享的,并且在所有受试者的肺部微生物组中均能持续检测到,与已知的抗生素暴露无关。总之,尽管群落的分类学存在波动,但发现微生物组相关基因总体稳定。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/651c3ee15b37/microorganisms-08-01003-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/a7594dd506ca/microorganisms-08-01003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/4ba5bb2618ec/microorganisms-08-01003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/d959475d64f7/microorganisms-08-01003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/44dea842b3f0/microorganisms-08-01003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/651c3ee15b37/microorganisms-08-01003-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/a7594dd506ca/microorganisms-08-01003-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/4ba5bb2618ec/microorganisms-08-01003-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/d959475d64f7/microorganisms-08-01003-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/44dea842b3f0/microorganisms-08-01003-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4817/7409339/651c3ee15b37/microorganisms-08-01003-g005.jpg

相似文献

1
Untargeted Metagenomic Investigation of the Airway Microbiome of Cystic Fibrosis Patients with Moderate-Severe Lung Disease.对患有中重度肺部疾病的囊性纤维化患者气道微生物群进行非靶向宏基因组学研究。
Microorganisms. 2020 Jul 4;8(7):1003. doi: 10.3390/microorganisms8071003.
2
Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.囊性纤维化患者的痰液 DNA 测序:非侵入性获取肺部微生物组和病原体详情。
Microbiome. 2017 Feb 10;5(1):20. doi: 10.1186/s40168-017-0234-1.
3
Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics.利用鸟枪法宏基因组学深入了解青少年囊性纤维化气道微生物组。
Int J Mol Sci. 2024 Mar 31;25(7):3893. doi: 10.3390/ijms25073893.
4
Supplemental Oxygen Alters the Airway Microbiome in Cystic Fibrosis.补充氧气会改变囊性纤维化患者的气道微生物组。
mSystems. 2022 Oct 26;7(5):e0036422. doi: 10.1128/msystems.00364-22. Epub 2022 Aug 24.
5
Meta-analysis of sputum microbiome studies identifies airway disease-specific taxonomic and functional signatures.痰液微生物组研究的荟萃分析确定了气道疾病特异性的分类学和功能特征。
J Med Microbiol. 2022 Dec;72(12). doi: 10.1099/jmm.0.001617.
6
Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.囊性纤维化肺部微生物组中包括捕食细菌在内的复杂性的个体模式,在 1 年期间的变化。
mBio. 2017 Sep 26;8(5):e00959-17. doi: 10.1128/mBio.00959-17.
7
Pediatric lung transplantation: Dynamics of the microbiome and bronchiolitis obliterans in cystic fibrosis.小儿肺移植:囊性纤维化中微生物组和闭塞性细支气管炎的动态变化。
J Heart Lung Transplant. 2020 Aug;39(8):824-834. doi: 10.1016/j.healun.2020.04.016. Epub 2020 May 19.
8
A Different Microbiome Gene Repertoire in the Airways of Cystic Fibrosis Patients with Severe Lung Disease.患有严重肺部疾病的囊性纤维化患者气道中不同的微生物组基因库。
Int J Mol Sci. 2017 Jul 29;18(8):1654. doi: 10.3390/ijms18081654.
9
High-Resolution Longitudinal Dynamics of the Cystic Fibrosis Sputum Microbiome and Metabolome through Antibiotic Therapy.囊性纤维化痰液微生物组和代谢组在抗生素治疗过程中的高分辨率纵向动态变化
mSystems. 2020 Jun 23;5(3):e00292-20. doi: 10.1128/mSystems.00292-20.
10
Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.不同的下一代测序平台在囊性纤维化痰液中产生不同的微生物谱和多样性。
J Microbiol Methods. 2016 Nov;130:95-99. doi: 10.1016/j.mimet.2016.09.002. Epub 2016 Sep 5.

引用本文的文献

1
Exploring the Complexity of the Human Respiratory Virome through an In Silico Analysis of Shotgun Metagenomic Data Retrieved from Public Repositories.通过对公共存储库中获取的鸟枪法宏基因组数据进行计算分析,探索人类呼吸道病毒组的复杂性。
Viruses. 2024 Jun 13;16(6):953. doi: 10.3390/v16060953.
2
Insights into the Adolescent Cystic Fibrosis Airway Microbiome Using Shotgun Metagenomics.利用鸟枪法宏基因组学深入了解青少年囊性纤维化气道微生物组。
Int J Mol Sci. 2024 Mar 31;25(7):3893. doi: 10.3390/ijms25073893.
3
The Impact of Antimicrobial Resistance in Cystic Fibrosis.

本文引用的文献

1
The Microbiome in Cystic Fibrosis Pulmonary Disease.囊性纤维化肺病中的微生物组。
Genes (Basel). 2020 May 11;11(5):536. doi: 10.3390/genes11050536.
2
Lung function and microbiota diversity in cystic fibrosis.囊性纤维化中的肺功能和微生物多样性。
Microbiome. 2020 Apr 2;8(1):45. doi: 10.1186/s40168-020-00810-3.
3
Deciphering the Ecology of Cystic Fibrosis Bacterial Communities: Towards Systems-Level Integration.解析囊性纤维化细菌群落的生态:迈向系统水平的整合。
囊性纤维化中抗菌药物耐药性的影响
J Clin Med. 2024 Mar 16;13(6):1711. doi: 10.3390/jcm13061711.
4
Positioning the preventive potential of microbiome treatments for cystic fibrosis in the context of current therapies.在当前疗法的背景下定位微生物组治疗囊性纤维化的预防潜力。
Cell Rep Med. 2024 Jan 16;5(1):101371. doi: 10.1016/j.xcrm.2023.101371.
5
The Cystic Fibrosis Upper and Lower Airway Metagenome.囊性纤维化上、下呼吸道宏基因组
Microbiol Spectr. 2023 Mar 9;11(2):e0363322. doi: 10.1128/spectrum.03633-22.
6
Antibiotic Resistance in Patients with Cystic Fibrosis: Past, Present, and Future.囊性纤维化患者的抗生素耐药性:过去、现在与未来
Antibiotics (Basel). 2023 Jan 20;12(2):217. doi: 10.3390/antibiotics12020217.
7
Impact of Elexacaftor/Tezacaftor/Ivacaftor Therapy on the Cystic Fibrosis Airway Microbial Metagenome.依伐卡托/泰他卡托/艾氟康唑治疗对囊性纤维化气道微生物宏基因组的影响。
Microbiol Spectr. 2022 Oct 26;10(5):e0145422. doi: 10.1128/spectrum.01454-22. Epub 2022 Sep 26.
8
Mapping bacterial diversity and metabolic functionality of the human respiratory tract microbiome.绘制人类呼吸道微生物组的细菌多样性和代谢功能图谱。
J Oral Microbiol. 2022 Mar 16;14(1):2051336. doi: 10.1080/20002297.2022.2051336. eCollection 2022.
9
Pseudomonas aeruginosa modulates alginate biosynthesis and type VI secretion system in two critically ill COVID-19 patients.铜绿假单胞菌在两名危重症COVID-19患者中调节藻酸盐生物合成和VI型分泌系统。
Cell Biosci. 2022 Feb 9;12(1):14. doi: 10.1186/s13578-022-00748-z.
10
Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of .囊性纤维化气道微生物群中的多微生物相互作用影响了……的抗菌敏感性 。 (原文结尾处不完整)
Antibiotics (Basel). 2021 Jul 7;10(7):827. doi: 10.3390/antibiotics10070827.
Trends Mol Med. 2019 Dec;25(12):1110-1122. doi: 10.1016/j.molmed.2019.07.008. Epub 2019 Aug 19.
4
Nasal Resistome Development in Infants With Cystic Fibrosis in the First Year of Life.囊性纤维化婴儿出生后第一年鼻腔耐药组的发育情况
Front Microbiol. 2019 Feb 26;10:212. doi: 10.3389/fmicb.2019.00212. eCollection 2019.
5
Understanding the impact of antibiotic therapies on the respiratory tract resistome: a novel pooled-template metagenomic sequencing strategy.了解抗生素治疗对呼吸道耐药基因组的影响:一种新型的混合模板宏基因组测序策略。
Multidiscip Respir Med. 2018 Aug 9;13(Suppl 1):30. doi: 10.1186/s40248-018-0140-9. eCollection 2018.
6
Profiling microbial strains in urban environments using metagenomic sequencing data.利用宏基因组测序数据对城市环境中的微生物菌株进行分析。
Biol Direct. 2018 May 9;13(1):9. doi: 10.1186/s13062-018-0211-z.
7
The Versatile Mutational Resistome of ..的多功能突变抗性组
Front Microbiol. 2018 Apr 6;9:685. doi: 10.3389/fmicb.2018.00685. eCollection 2018.
8
On the Road to Strain-Resolved Comparative Metagenomics.迈向菌株解析比较宏基因组学之路
mSystems. 2018 Mar 13;3(2). doi: 10.1128/mSystems.00190-17. eCollection 2018 Mar-Apr.
9
Fluctuations in airway bacterial communities associated with clinical states and disease stages in cystic fibrosis.气道细菌群落随囊性纤维化临床状态和疾病阶段的波动。
PLoS One. 2018 Mar 9;13(3):e0194060. doi: 10.1371/journal.pone.0194060. eCollection 2018.
10
Airway microbiota across age and disease spectrum in cystic fibrosis.囊性纤维化患者气道微生物组的年龄与疾病谱特征。
Eur Respir J. 2017 Nov 16;50(5). doi: 10.1183/13993003.00832-2017. Print 2017 Nov.